Jorge Tolivia Selected Research

Apolipoproteins D (Apo D)

1/2021	Neuroprotective Effect of Apolipoprotein D in Cuprizone-Induced Cell Line Models: A Potential Therapeutic Approach for Multiple Sclerosis and Demyelinating Diseases.
1/2018	Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions.
1/2016	Apo J and Apo D: Complementary or Antagonistic Roles in Alzheimer's Disease?
7/2015	Apolipoprotein D subcellular distribution pattern in neuronal cells during oxidative stress.
1/2013	Oxidative stress induces apolipoprotein D overexpression in hippocampus during aging and Alzheimer's disease.
1/2013	Lifelong expression of apolipoprotein D in the human brainstem: correlation with reduced age-related neurodegeneration.
2/2012	Gender differences in apolipoprotein D expression during aging and in Alzheimer disease.
3/2010	Apolipoprotein D synthesis progressively increases in frontal cortex during human lifespan.
1/2008	Apolipoprotein D expression absence in degenerating neurons of human central nervous system.
12/2003	Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jorge Tolivia Research Topics

Disease

6	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 12/2003
5	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2015 - 01/2008
3	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 01/2018
2	Multiple Sclerosis 01/2021 - 01/2018
2	Amyloid Plaque 01/2016 - 12/2003
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2012 - 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2021
1	Neuroblastoma 01/2021
1	Sclerosis 01/2018
1	Dementia (Dementias) 06/2013
1	Memory Disorders (Memory Loss) 06/2013
1	Cognitive Dysfunction 06/2013
1	Breast Cyst 02/2012
1	Gestational Diabetes (Gestational Diabetes Mellitus) 09/2006
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 12/2003

Drug/Important Bio-Agent (IBA)

10	Apolipoproteins D (Apo D)IBA 01/2021 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 09/2006
3	ApolipoproteinsIBA 01/2021 - 12/2003
2	CuprizoneIBA 02/2021 - 01/2021
2	Estrogens (Estrogen)FDA Link 06/2013 - 02/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2012 - 12/2003
1	Neuroprotective AgentsIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2013
1	SolutionsIBA 01/2013
1	Congo RedIBA 01/2013
1	LipidsIBA 01/2013
1	AntioxidantsIBA 01/2013
1	ParaffinIBA 01/2013
1	LipocalinsIBA 01/2008
1	Insulin (Novolin)FDA Link 09/2006
1	Apolipoproteins E (ApoE)IBA 12/2003